Celularity flags Fontaine Vitale strategic collaboration ahead of Q1 2027 opening in Bali
CELU•Celularity said it is collaborating with Fontaine Vitale, a regenerative medicine and wellness center expected to open in Bali in Q1 2027, and expects to supply its placenta-derived cellular therapy products subject to commercial terms and regulatory authorizations.
1. Bali collaboration
Celularity said Fontaine Vitale, a regenerative medicine and wellness center in Bali’s Sanur SEZ, is a strategic partner ahead of its planned Q1 2027 opening. Genting Berhad and Indonesian partners are developing the facility, with Celularity providing strategic collaboration and input.
2. Expected product supply
Celularity expects to supply placenta-derived cellular therapy products made in New Jersey, subject to final commercial terms and regulatory authorizations. The company said the partnership represents an entry into the Asia-Pacific market and targets incremental revenue as patient volumes ramp after opening.
